在Trypanosomatids中进行药物干预的聚胺代谢
Yolanda Pérez-Pertejo1,2, Carlos García-Estrada1,2, María Martínez-Valladares3
1Departamento de Ciencias Biomédicas, Campus de Vegazana s/n, Universidad de León, 24071 León, Spain.
Pathogens (Basel, Switzerland)
|January 22, 2024
概括
针对聚胺代谢提供了一个有希望的策略,用于开发新的药物来对抗被忽视的热带疾病,如睡眠病和查加斯病. 研究重点是聚胺合成抑制剂及其在寄生虫中的独特途径.
科学领域:
- * 寄生虫学和热带医学
- * 分子生物学和生物化学
- * 药物发现和开发
背景情况:
- *被忽视的热带疾病,包括非洲试索米病,查加斯病和莱什曼病,不成比例地影响贫困人口.
- *多氨酸 (氨酸,精氨酸,精氨酸) 是细胞生长的必需代谢物,使其代谢成为治疗干预的目标.
- *以前试图抑制癌症和传染病的聚胺合成的尝试取得了有限的成功,但eflornithine (DFMO) 对睡眠疾病的疗效激发了新的兴趣.
研究的目的:
- * 审查当前关于基于聚胺的治疗试索马提德传播的被忽视的热带疾病的研究.
- * 探索开发针对聚胺代谢的新型治疗剂的趋势和挑战.
- *强调了解寄生虫特异性代谢途径对于药物开发的重要性.
主要方法:
- * 关于试类动物中聚胺代谢的科学文献的综述.
- * 对药物发现工作的分析,以聚胺途径中的酶为目标.
- * 对寄生虫中聚胺吸收和氧化还原平衡机制的研究.
主要成果:
- * 埃弗洛尼丁 (DFMO) 证明了对睡眠疾病的成功,验证了抑制聚胺合成作为治疗策略.
- *聚胺合成抑制剂提供了对宿主-寄生虫代谢差异和物种特定途径的见解.
- * 确定关键的分子标,包括小鸟素脱碳酶,S-adenosylmethionine脱碳酶和精子素合成酶.
结论:
- * 聚胺新陈代谢仍然是开发针对被忽视的热带疾病的新药的可行和重要目标.
- *进一步研究基于目标的支架和特定的化学实体对于克服当前挑战至关重要.
- * 了解不同类型的试索马蒂中独特的聚胺通路是设计有效和选择性治疗的关键.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Enhanced Elimination of Poison
514
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
514
Anticholinesterase Agents: Poisoning and Treatment
861
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
861
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
238
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
238
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K


